2025-08-29 - Analysis Report
Okay, here's an analysis of Colgate-Palmolive (CL) based on the provided data.

## Colgate-Palmolive (CL) Stock Analysis

**Colgate-Palmolive Co: A global consumer products company focusing on household, health care, and personal care products.**

### 1. Performance vs. S&P 500 (VOO)

*   **Cumulative Return (CL):** 10.75%
*   **Cumulative Return (VOO):** 102.60%
*   **Absolute Divergence (Last Day):** -191.8
*   **Relative Divergence:** 0.2

**Analysis:** Colgate-Palmolive has significantly underperformed the S&P 500 over the period represented by the cumulative returns. The negative divergence indicates a substantial gap in performance, with CL lagging far behind VOO. The Relative Divergence of 0.2 suggests CL's performance is near the bottom end of its historical divergence range compared to VOO.

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD    | Alpha   | Beta   | Cap(B) |
|------------|--------|--------|---------|--------|--------|
| 2015-2017  | 13.0%  | 4.5%   | -16.0%  | 0.0    | 61.0   |
| 2016-2018  | -11.0% | 65.2%  | -29.0%  | 0.1    | 48.1   |
| 2017-2019  | 7.0%   | 65.2%  | -22.0%  | 0.1    | 55.6   |
| 2018-2020  | 18.0%  | 65.2%  | -2.0%   | 0.6    | 69.1   |
| 2019-2021  | 30.0%  | 58.6%  | -19.0%  | 0.7    | 69.0   |
| 2020-2022  | 7.0%   | 69.0%  | 5.0%    | 0.7    | 63.7   |
| 2021-2023  | 6.0%   | 69.0%  | -12.0%  | 0.8    | 64.4   |
| 2022-2024  | 13.0%  | 69.0%  | -12.0%  | 0.8    | 73.5   |
| 2023-2025  | -2.0%  | 70.6%  | -57.0%  | 0.3    | 67.4   |

**Analysis:**

*   **CAGR (Compound Annual Growth Rate):** Varies significantly across periods, showing some positive growth but a recent decline.
*   **MDD (Maximum Drawdown):** Relatively high MDD values suggest periods of significant price decline.
*   **Alpha:** Predominantly negative alpha values indicate underperformance relative to the market, except for the 2020-2022 period.  The recent 2023-2025 period shows a significantly negative alpha.
*   **Beta:** Low beta values (mostly below 1) suggest that CL is less volatile than the overall market (S&P 500).
*   **Cap(B):** Market capitalization remains relatively stable.

### 2. Recent Stock Price Movements

*   **Current Price:** 83.42
*   **Previous Close:** 84.45
*   **Change:** -1.22
*   **5-Day Moving Average:** 84.40
*   **20-Day Moving Average:** 84.69
*   **60-Day Moving Average:** 87.77

**Analysis:** The stock price is currently below all three moving averages (5-day, 20-day, and 60-day). The recent price decline and the fact that the 5-day moving average is below the 20-day moving average suggests a short-term downtrend.

### 3. Market Risk Indicators and Signals

*   **Market Risk Indicator (MRI):** 0.3266 (Low Risk)
*   **RSI (Relative Strength Index):** 44.07
*   **PPO (Percentage Price Oscillator):** 0.0222
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (1209 shares - Safe (OverSold Boost) - MRI:0.32)
*   **Recent (20-day) Relative Divergence Change:** 0.0 (Negative)
*   **Expected Return (%):** -10802.4%

**Analysis:**

*   **MRI:** The low MRI suggests relatively low market risk.
*   **RSI:** An RSI of 44.07 is near the neutral level, indicating neither overbought nor oversold conditions.
*   **PPO:** A PPO close to zero indicates little momentum.
*   **Hybrid Signal:** The signal suggests a "Buy" recommendation based on oversold conditions and the low MRI.
*   **Recent Relative Divergence Change:** No change in the divergence over the last 20 days implies a consistent underperformance trend.
*   **Expected Return:** The significantly negative expected return suggests potential underperformance compared to the S&P 500 over a long-term investment horizon.
*   **Price Change:** The recent price change of -1.22 indicates a short-term drop in stock value, potentially contributing to the oversold signal.

### 4. Recent News & Significant Events

*   **2025-08-26:** Major business developments, regulatory changes, or market events.
*   **2025-08-28:** Analyst discussions about recent performance and outlook in the context of industry trends and global economic factors.
*   **2025-08-27:** Notable stock volatility, influenced by recent news, earnings reports, or executive actions.
*   **2025-08-29:** Market experts highlighting both risks and opportunities, advising investors to monitor recent news and company announcements.

**Analysis:** Recent news suggests a dynamic environment for Colgate-Palmolive, with volatility and analyst discussions focused on both opportunities and risks. These events might be contributing to the stock's recent performance and volatility.

### 5. Recent Earnings Analysis

| Date       | EPS  | Revenue |
|------------|------|---------|
| 2025-08-01 | 0.92 | 5.11 B$ |
| 2025-04-25 | 0.85 | 4.91 B$ |
| 2024-10-25 | 0.90 | 5.03 B$ |
| 2024-07-26 | 0.89 | 5.06 B$ |
| 2025-08-01 | 0.89 | 5.06 B$ |

**Analysis:**

*   EPS and Revenue have been relatively stable over the recent quarters, with slight fluctuations.
*   The most recent quarter (2025-08-01) shows a strong EPS, indicating improved profitability.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue  | Profit Margin |
|------------|----------|---------------|
| 2025-06-30 | $5.11B   | 60.06%        |
| 2025-03-31 | $4.91B   | 60.82%        |
| 2024-12-31 | $4.95B   | 60.30%        |
| 2024-09-30 | $5.03B   | 61.08%        |
| 2024-06-30 | $5.06B   | 60.62%        |

**Capital and Profitability:**

| Quarter    | Equity   | ROE       |
|------------|----------|-----------|
| 2025-06-30 | $0.70B   | 105.84%   |
| 2025-03-31 | $0.36B   | 190.08%   |
| 2024-12-31 | $0.21B   | 348.58%   |
| 2024-09-30 | $0.43B   | 169.43%   |
| 2024-06-30 | $0.12B   | 594.31%   |

**Analysis:**

*   **Revenue:** Relatively stable over the last five quarters.
*   **Profit Margin:** Consistently high, indicating strong profitability.
*   **Equity:** Fluctuates, possibly reflecting changes in assets and liabilities.
*   **ROE (Return on Equity):** Extremely high ROE values suggest efficient use of equity to generate profits, but also warrant further investigation into the sustainability and drivers behind these high returns.

### 7. Overall Summary

Colgate-Palmolive (CL) has significantly underperformed the S&P 500, with a substantial negative divergence in cumulative returns. The stock is currently in a short-term downtrend, trading below its moving averages. While the MRI suggests low market risk and the Hybrid Signal indicates oversold conditions, the significantly negative expected return raises concerns about its long-term potential compared to the broader market.  Recent news and events indicate a dynamic environment, with volatility and analyst discussions focused on both risks and opportunities.  Earnings and revenue have been relatively stable, with high profit margins and ROE, but further analysis is needed to assess the sustainability of these high returns. Overall, investors should exercise caution and conduct further research before considering a long-term investment in Colgate-Palmolive.
